Treatment of Ocular Larva Migrans with Choroidal Neovascularization Secondary to Ocular Toxocariasis

This protocol applies to patients with ocular larva migrans who develop choroidal neovascularization (CNV) as a complication of ocular toxocariasis — a specific presentation requiring targeted intervention for the neovascular process arising in this infectious context.

Choroidal neovascularization secondary to ocular toxocariasis defines the clinical context driving treatment selection in this protocol. The neovascular complication has been specifically investigated in the setting of ocular toxocariasis, and this evidence shapes the recommended approach.

An intravitreal anti-VEGF agent has been reported as effective for this neovascular complication. The complete structured regimen — including specific agent, administration schedule, and follow-up criteria — is available in the full protocol.